JavaScript is disabled. Please enable to continue!

Mobile search icon
BioPharma Services >> CDMO >> Analytical Services

Analytical Services

Sidebar Image

Eurofins CDMO network of companies offers analytical method development & validation services as part of API development as well as stand-alone analytical testing services for projects at various stages in the drug life cycle (pre-clinical to late phase). Our analytical scientists specialize in the development of analytical methods and phase appropriate specifications to ensure control of the synthetic process and quality throughout the program.

Services

Analytical Method Development

  • Method Development
  • In-Process Controls
  • Method Optimization
  • Suitability Testing
  • Starting Material, Intermediate & API Release
  • Impurity Characterization
  • Impurity Isolation
  • GTI Control
  • PGI Control
  • Non-Chromophoric Detection (CAD, ELS, MS, RI)
  • Specification Development

Analytical Method Qualification / Validation

  • Method Establishment
  • Method Transfer
  • Phase Appropriate Method Qualification
  • Method Verification
  • Full Method Validation

Standard Qualifications

  • Identification Standards
  • Physical & Structure Characterization
  • Reference Standards

Lifecycle Optimization

  • DOE Studies
  • CPP Assessment/Support
  • Fate of Impurities
  • Regulatory GAP Assessment
  • CMC Support

Stability

  • Short Term Stability Studies
  • ICH Stability Studies
  • Photo Stability (ICH Q1B)
  • Forced Degradation Studies
  • Trending Studies and Reporting